Headquarters: Zurich, Switzerland
CEO: Mr. Wern-Yi Goh
CHF as of April 1, 2022
Achiko AG, together with its subsidiaries, engages in the healthtech business in Indonesia, Singapore, and Hong Kong. The company develops Teman Sehat, a mobile app with a digital passporting service that manages the booking, payment, and diagnostic testing for Covid-19; and AptameX, a saliva-based diagnostic test for the detection of Covid-19. It also offers secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. The company was incorporated in 2018 and is headquartered in Zürich, Switzerland.
Achiko AG has the following listings and related stock indices.
Stock: SIX: ACHI